Streetbeat News

Price Targets

PRTG

Cantor Fitzgerald analyst Li Watsek has maintained an Overweight rating on Portage Biotech (NASDAQ:PRTG) but lowered the price target from $16 to $11.

Portfolio Pulse from richadhand@benzinga.com

August 01, 2023 | 2:55 pm

BMRN

Cantor Fitzgerald analyst Olivia Brayer has reiterated an Overweight rating on Biomarin Pharmaceutical (NASDAQ:BMRN) and maintained a price target of $120.

Portfolio Pulse from richadhand@benzinga.com

August 01, 2023 | 2:54 pm

EVEX

Cantor Fitzgerald analyst Andres Sheppard has reiterated a Neutral rating on Eve Holding (NYSE:EVEX) and maintained a $7 price target.

Portfolio Pulse from richadhand@benzinga.com

August 01, 2023 | 2:53 pm

HCAT

Cantor Fitzgerald analyst Steven Halper has initiated coverage on Health Catalyst (NASDAQ:HCAT) with an Overweight rating and a price target of $16.

Portfolio Pulse from richadhand@benzinga.com

August 01, 2023 | 2:53 pm

AAPL

TD Cowen analyst Krish Sankar maintains an Outperform rating on Apple (NASDAQ:AAPL) and raises the price target from $195 to $220.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 01, 2023 | 2:51 pm

VRNS

TD Cowen analyst Shaul Eyal maintains an Outperform rating on Varonis Systems (NASDAQ:VRNS) and raises the price target from $35 to $37.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 01, 2023 | 2:50 pm

CRS

TD Cowen analyst Gautam Khanna maintains an Outperform rating on Carpenter Tech (NYSE:CRS) and raises the price target from $60 to $72.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 01, 2023 | 2:48 pm

MPWR

Truist Securities analyst William Stein maintains a 'Buy' rating on Monolithic Power Systems (NASDAQ:MPWR) and raises the price target from $527 to $600.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2023 | 2:47 pm

CEQP

Truist Securities analyst Neal Dingmann maintains a 'Buy' rating on Crestwood Equity Partners (NYSE:CEQP) and raises the price target from $30 to $31.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2023 | 2:47 pm

VRNS

Piper Sandler analyst Rob Owens maintains a Neutral rating on Varonis Systems (NASDAQ:VRNS) and raises the price target from $25 to $30.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 01, 2023 | 2:46 pm